We use some of the world's most advanced capabilities in multiomics and data analysis to deliver unique insights for improving the diagnosis, treatment, and prevention of the biggest challenges in human health.
Our AI / ML scientists are tackling some of the biggest challenges in medicine.
Our team has a significant track record of landmark advances in the application of machine learning and unconventional computing to human biology. Peer-reviewed and published, our innovative applications of five core pillars of know-how span a broad range of capabilities, diseases and challenges from drug discovery and development to digital medicine.
Partner Spotlight
Ionis Pharmaceuticals and Genuity Science have partnered on the discovery of up to 20 novel targets rooted in the underlying biology of a range of diseases.
“I’m convinced that the way Genuity Science is working is the future of genomic research.”
Hear from Leo Saheljio, MD, VP of Translational Medicine on the announcement of the collaboration, and why Ionis chose Genuity Science as a partner for this work.
Our world-leading genomics platform facilitates fast and easy querying of the UKBB sequence and phenotype data to drive insights from the dataset – enabling us to help you to answer key questions across the drug development process.
This website stores cookies on your computer. Some of these cookies enable this website to function and some of these cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy and Privacy Policy.
